<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39375883</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0258</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Statistics in medicine</Title><ISOAbbreviation>Stat Med</ISOAbbreviation></Journal><ArticleTitle>Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group-Tested Data.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/sim.10230</ELocationID><Abstract><AbstractText>We consider the problem of combining multiple biomarkers to improve the diagnostic accuracy of detecting a disease when only group-tested data on the disease status are available. There are several challenges in addressing this problem, including unavailable individual disease statuses, differential misclassification depending on group size and number of diseased individuals in the group, and extensive computation due to a large number of possible combinations of multiple biomarkers. To tackle these issues, we propose a pairwise model fitting approach to estimating the distribution of the optimal linear combination of biomarkers and its diagnostic accuracy under the assumption of a multivariate normal distribution. The approach is evaluated in simulation studies and applied to data on chlamydia detection and COVID-19 diagnosis.</AbstractText><CopyrightInformation>Published 2024. This article is a U.S. Government work and is in the public domain in the USA. Statistics in Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0625-5189</Identifier><AffiliationInfo><Affiliation>Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-4315-8380</Identifier><AffiliationInfo><Affiliation>Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0003-1658-1068</Identifier><AffiliationInfo><Affiliation>Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Aiyi</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6618-5082</Identifier><AffiliationInfo><Affiliation>Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-9946-1362</Identifier><AffiliationInfo><Affiliation>Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022YFA1004800</GrantID><Agency>National Key Research and Development Program of China</Agency><Country /></Grant><Grant><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>12001522</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>72091212</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><Agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stat Med</MedlineTA><NlmUniqueID>8215016</NlmUniqueID><ISSNLinking>0277-6715</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AUC</Keyword><Keyword MajorTopicYN="N">differential misclassification</Keyword><Keyword MajorTopicYN="N">joint model</Keyword><Keyword MajorTopicYN="N">multiple biomarkers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39375883</ArticleId><ArticleId IdType="doi">10.1002/sim.10230</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>J. A. Hanley and B. J. McNeil, “The Meaning and Use of the Area Under a Receiver Operating Characteristic (ROC) Curve,” Radiology 143 (1982): 29–36.</Citation></Reference><Reference><Citation>S. Wieand, M. H. Gail, B. R. James, and K. L. James, “A Family of Nonparametric Statistics for Comparing Diagnostic Markers With Paired or Unpaired Data,” Biometrika 76 (1989): 585–592.</Citation></Reference><Reference><Citation>K. H. Zou and W. J. Hall, “Semiparametric and Parametric Transformation Models for Comparing Diagnostic Markers With Paired Design,” Journal of Applied Statistics 29 (2002): 803–816.</Citation></Reference><Reference><Citation>H. Yang, K. Lu, and Y. Zhao, “A Nonparametric Approach for Partial Areas Under ROC Curves and Ordinal Dominance Curves,” Statistica Sinica 27, no. 1 (2017): 357–371.</Citation></Reference><Reference><Citation>J. Yin and L. Tian, “Joint Confidence Region Estimation for Area Under ROC Curve and Youden Index,” Statistics in Medicine 33, no. 6 (2014): 985–1000.</Citation></Reference><Reference><Citation>J. Q. Su and J. S. Liu, “Linear Combinations of Multiple Diagnostic Markers,” Journal of the American Statistical Association 88 (1993): 1350–1355.</Citation></Reference><Reference><Citation>A. Liu, E. Schisterman, and Y. Zhu, “On Linear Combinations of Biomarkers to Improve Diagnostic Accuracy,” Statistics in Medicine 24, no. 1 (2005): 37–47.</Citation></Reference><Reference><Citation>R. Dorfman, “The Detection of Defective Members of Large Populations,” Annals of Mathematical Statistics 14 (1943): 436–440.</Citation></Reference><Reference><Citation>M. Sobel and R. M. Elashoff, “Group Testing With a New Goal, Estimation,” Biometrika 62, no. 1 (1975): 181–193.</Citation></Reference><Reference><Citation>C. T. Le, “A New Estimator for Infection Rates Using Pools of Variable Size,” American Journal of Epidemiology 114, no. 1 (1981): 132–136.</Citation></Reference><Reference><Citation>J. L. Gastwirth and P. A. Hammick, “Estimation of Prevalence of a Rare Disease, Preserving Anonymity of Subjects by Group Testing: Application to Estimating the Prevalence of Aids Antibodies in Blood Donors,” Journal of Statistical Planning and Inference 22 (1989): 15–27.</Citation></Reference><Reference><Citation>C. P. Farrington, “Estimating Prevalence by Group Testing Using Generalized Linear Models,” Statistics in Medicine 11, no. 12 (1992): 1591–1597.</Citation></Reference><Reference><Citation>G. Hepworth, “Exact Confidence Intervals for Proportions Estmated by Group Testing,” Biometrics 52 (1996): 1134–1146.</Citation></Reference><Reference><Citation>J. M. Hughes‐Oliver and W. F. Rosenberger, “Efficient Estimation of the Prevalence of Multiple Rare Traits,” Biometrika 87 (2000): 315–327.</Citation></Reference><Reference><Citation>D. W. Turner, J. D. Stamey, and D. M. Young, “Classic Group Testing With Cost for Grouping and Testing,” Computers &amp; Mathematics with Applications 58, no. 10 (2009): 1930–1935.</Citation></Reference><Reference><Citation>M. Warasi, J. Tebbs, C. McMahan, and C. Bilder, “Estimating the Prevalence of Multiple Diseases From Two‐Stage Hierarchical Pooling,” Statistics in Medicine 35 (2016): 3851–3864.</Citation></Reference><Reference><Citation>Y. Malinovsky, G. Haber, and P. S. Albert, “An Optimal Design for Hierarchical Generalized Group Testing,” Journal of the Royal Statistical Society, Series C 69, no. 3 (2020): 607–621.</Citation></Reference><Reference><Citation>C. L. Chen and W. H. Swallow, “Using Group Testing to Estimate a Proportion, and to Test the Binomial Model,” Biometrics 46 (1990): 1035–1046.</Citation></Reference><Reference><Citation>R. Brookmeyer, “Analysis of Multistage Pooling Studies of Biological Specimens for Estimating Disease Incidence and Prevalence,” Biometrics 55, no. 2 (1999): 608–612.</Citation></Reference><Reference><Citation>B. Zhang, C. R. Bilder, and J. M. Tebbs, “Group Testing Regression Model Estimation When Case Identification Is a Goal,” Biometrical Journal 55, no. 2 (2013): 173–189.</Citation></Reference><Reference><Citation>M. S. Black, C. R. Bilder, and J. M. Tebbs, “Optimal Retesting Configurations for Hierarchical Group Testing,” Journal of the Royal Statistical Society, Series C 64, no. 4 (2015): 693–710.</Citation></Reference><Reference><Citation>G. Hepworth and R. Watson, “Revisiting Retesting in the Estimation of Proportions by Group Testing,” Communications in Statistics ‐ Simulation and Computation 46, no. 1 (2017): 261–274.</Citation></Reference><Reference><Citation>W. Zhang, A. Liu, Q. Li, and P. S. Albert, “Incorporating Retesting Outcomes for Estimation of Disease Prevalenceon,” Statistics in Medicine 39, no. 6 (2020): 687–697.</Citation></Reference><Reference><Citation>J. M. Tebbs, C. S. McMahan, and C. R. Bilder, “Two‐Stage Hierarchical Group Testing for Multiple Infections With Application to the Infertility Prevention Project,” Biometrics 69, no. 4 (2013): 1064–1073.</Citation></Reference><Reference><Citation>Q. Li, A. Liu, and W. Xiong, “D‐Optimality of Group Testing for Joint Prevalence Estimation of Correlated Rare Diseases in the Presence of Misclassification,” Statistics in Medicine 27 (2017): 823–838.</Citation></Reference><Reference><Citation>M. S. Warasi, J. M. Tebbs, C. S. McMahan, and C. R. Bilder, “Estimating the Prevalence of Two or More Diseases Using Outcomes From Multiplex Group Testing,” Biometrical Journal 65, no. 7 (2023): 2200270.</Citation></Reference><Reference><Citation>W. Zhang, A. Liu, Q. Li, and P. S. Albert, “Nonparametric Estimation of Distributions and Diagnostic Accuracy Based on Group‐Tested Results With Differential Misclassification,” Biometrics 76, no. 4 (2020): 1147–1156.</Citation></Reference><Reference><Citation>G. Haber, Y. Malinovsky, and P. S. Albert, “Is Group Testing Ready for Prime‐Time in Disease Identification?,” Statistics in Medicine 40, no. 17 (2021): 3865–3880.</Citation></Reference><Reference><Citation>S. Fieuws and G. Verbeke, “Pairwise Fitting of Mixed Models for the Joint Modeling of Multivariate Longitudinal Profiles,” Biometrics 62, no. 2 (2006): 424–431.</Citation></Reference><Reference><Citation>W. Kassahun‐Yimer, P. S. Albert, L. M. Lipsky, T. R. Nansel, and A. Liu, “A Joint Model for Multivariate Hierachical Semicontinuous Data With Replications,” Statistical Methods in Medical Research 28, no. 3 (2019): 858–870.</Citation></Reference><Reference><Citation>F. K. Hwang, “Group Testing With a Dilution Effect,” Biometrika 63 (1976): 671–680.</Citation></Reference><Reference><Citation>M. Hung and W. Swallow, “Robustness of Group Testing in the Estimation of Proportions,” Biometrics 55 (1999): 231–237.</Citation></Reference><Reference><Citation>S. Fieuws, G. Verbeke, and G. Molenberghs, “Random‐Effects Models for Multivariate Repeated Measures,” Statistical Methods in Medical Research 16 (2007): 387–397.</Citation></Reference><Reference><Citation>J. Besag, “Statistical Analysis of Non‐lattice Data,” Statistician 24, no. 3 (1975): 179–195.</Citation></Reference><Reference><Citation>S. J. Devlin, R. Gnanadesikan, and J. R. Kettenring, “Robust Estimation and Outlier Detection With Correlation Coefficients,” Biometrika 62, no. 3 (1975): 531–545.</Citation></Reference><Reference><Citation>K. H. Zou, A. Liu, A. I. Bandos, L. Ohno‐Machado, and H. E. Rockette, Statistical Evaluation of Diagnostic Performance: Topics in ROC Analysis (Boca Raton, FL: Chapman and Hall/CRC, 2012).</Citation></Reference><Reference><Citation>N. Sattar, F. K. Ho, J. M. Gill, et al., “BMI and Future Risk for COVID‐19 Infection and Death Across Sex, Age and Ethnicity: Preliminary Findings From UK Biobank,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews 14, no. 5 (2020): 1149–1151.</Citation></Reference><Reference><Citation>Z. Liu, J. Li, W. Long, et al., “Bilirubin Levels as Potential Indicators of Disease Severity in Coronavirus Disease Patients: A Retrospective Cohort Study,” Frontiers in Medicine 7 (2020), https://doi.org/10.3389/fmed.2020.598870.</Citation></Reference><Reference><Citation>N. Ali, “Relationship Between COVID‐19 Infection and Liver Injury: A Review of Recent Data,” Frontiers in Medicine 7, no. 458 (2020), https://doi.org/10.3389/fmed.2020.00458.</Citation></Reference><Reference><Citation>B. Kasapoglu, A. Yozgat, A. Tanoglu, G. Can, Y. S. Sakin, and M. Kekilli, “Gamma‐Glutamyl‐Transferase May Predict COVID‐19 Outcomes in Hospitalised Patients,” International Journal of Clinical Practice 75 (2021): e14933, https://doi.org/10.1111/ijcp.14933.</Citation></Reference><Reference><Citation>B. Datta, F. Njau, J. Thalmann, H. Haller, and A. D. Wagner, “Differential Infection Outcome of Chlamydia Trachomatis in Human Blood Monocytes and Monocyte‐Derived Dendritic Cells,” BMC Microbiology 14, no. 209 (2014), https://doi.org/10.1186/s12866‐014‐0209‐3.</Citation></Reference><Reference><Citation>E. K. Naglak, S. G. Morrison, and R. P. Morrison, “Neutrophils Are Central to Antibody‐Mediated Protection Against Genital Chlamydia,” Infection and Immunity 85, no. 10 (2017): e00409–e00417.</Citation></Reference><Reference><Citation>G. V. Stokes and N. B. Isada, “Albumin Enhances Chlamydial Infectivity on Human Placental Cells,” Microbios 65 (1991): 179–186.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>